GB201308117D0 - Inhibitor of calcifying disorders - Google Patents

Inhibitor of calcifying disorders

Info

Publication number
GB201308117D0
GB201308117D0 GBGB1308117.9A GB201308117A GB201308117D0 GB 201308117 D0 GB201308117 D0 GB 201308117D0 GB 201308117 A GB201308117 A GB 201308117A GB 201308117 D0 GB201308117 D0 GB 201308117D0
Authority
GB
United Kingdom
Prior art keywords
calcifying
disorders
inhibitor
calcifying disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1308117.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GBGB1308117.9A priority Critical patent/GB201308117D0/en
Publication of GB201308117D0 publication Critical patent/GB201308117D0/en
Priority to PCT/EP2014/059245 priority patent/WO2014180851A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
GBGB1308117.9A 2013-05-06 2013-05-06 Inhibitor of calcifying disorders Ceased GB201308117D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1308117.9A GB201308117D0 (en) 2013-05-06 2013-05-06 Inhibitor of calcifying disorders
PCT/EP2014/059245 WO2014180851A1 (en) 2013-05-06 2014-05-06 Inhibitor of calcifying disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1308117.9A GB201308117D0 (en) 2013-05-06 2013-05-06 Inhibitor of calcifying disorders

Publications (1)

Publication Number Publication Date
GB201308117D0 true GB201308117D0 (en) 2013-06-12

Family

ID=48627339

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1308117.9A Ceased GB201308117D0 (en) 2013-05-06 2013-05-06 Inhibitor of calcifying disorders

Country Status (2)

Country Link
GB (1) GB201308117D0 (en)
WO (1) WO2014180851A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5431098A (en) * 1996-11-07 1998-05-29 Wistar Institute Of Anatomy And Biology, The Sparc-deficient transgenic mice
EP1444260A4 (en) * 1999-05-14 2004-08-25 Millennium Pharm Inc Secreted proteins and uses thereof
US7572763B2 (en) * 2002-02-21 2009-08-11 Wyeth Follistatin domain containing proteins
WO2005046455A2 (en) * 2003-11-12 2005-05-26 Ping Gao Methods for identifying or monitoring a patient with increased risk of cardiovascular calcification
WO2010017102A2 (en) * 2008-08-06 2010-02-11 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Methods for intracellular modulation of bone morphogenetic protein signaling

Also Published As

Publication number Publication date
WO2014180851A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
HK1212691A1 (en) Inhibitors of the kynurenine pathway
IL279682A (en) Benzoquinolone inhibitors of vmat2
HK1248217A1 (en) Solid forms of a selective cdk4/6 inhibitor
IL243976B (en) Kdm1a inhibitors for the treatment of disease
SI3080100T1 (en) Inhibitors of lysine specific demethylase-1
HK1219421A1 (en) Combination of kinase inhibitors and uses thereof
HK1222339A1 (en) Inhibitors of metallo-ss-lactamase-enzymes --
EP3632467C0 (en) Inhibitors of complement factor h
HK1221645A1 (en) Benzoquinolone inhibitors of vmat2 vmat2
IL240763A0 (en) Halogenopyrazoles as inhibitors of therombin
ZA201507100B (en) Synthesis of bace1 inhibitors
HK1222386A1 (en) N-cyanomethylamides as inhibitors of janus kinase n-
GB201308117D0 (en) Inhibitor of calcifying disorders
GB201323021D0 (en) Use of kinase inhibitors
GB201321227D0 (en) Use of kinase inhibitors
GB201305503D0 (en) Inhibitor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)